We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 84 results
  1. Optimal ICSI timing on immature oocytes for low prognosis patients under the POSEIDON classification

    Background

    The optimal timing of performing ICSI on immature oocytes for POSEIDON patients is still unknown to get better early embryonic development...

    Cheng Shi, ** Wang, ... ** Chen in BMC Pregnancy and Childbirth
    Article Open access 06 June 2024
  2. What is the optimal number of embryos to transfer for POSEIDON group 1 and group 2? A retrospective study

    Background

    The 2016 Patient-Oriented Strategy Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria redefined the poor responders as low...

    Rang Liu, Qiuju Zhang, ... ** **a in Journal of Ovarian Research
    Article Open access 31 May 2024
  3. Maternal and neonatal complications after IVF/ICSI-fresh embryo transfer in low-prognosis women under the POSEIDON criteria: a retrospective cohort study

    Background

    Several studies on pregnancy complications of poor ovarian response (POR) patients did not draw a consistent conclusion. The POSEIDON...

    Shiguang Li, Huifang Tan, ... Yingying Qin in BMC Pregnancy and Childbirth
    Article Open access 12 December 2023
  4. Do we overlook predictive factors in Poseidon 1 patients? A retrospective analysis co-evaluating antral follicle counts & diameters

    Background

    An unexpected impaired ovarian response pertains to an insufficient reaction to controlled ovarian hyperstimulation. This deficient...

    Gürkan Uncu, Kiper Aslan, ... Carlo Alviggi in Journal of Ovarian Research
    Article Open access 02 January 2024
  5. Effectiveness of GnRH Agonist Short Protocol Versus GnRH Antagonist Protocol in POSEIDON Groups 3 and 4: a Retrospective Cohort Study

    The aim of this study is to compare the ART (assisted reproductive technology) outcomes and cancellation rates between GnRH antagonist protocol and...

    Atri Pal, Thenmozhi Mani, ... Mohan S. Kamath in Reproductive Sciences
    Article 17 February 2023
  6. Ultra-low–dose and very-low–dose Lupron downregulation protocols for poor responders based on POSEIDON group 3 and 4 classifications

    Purpose

    The objective of this study was to assess if very-low–dose Lupron (VLDL) and ultra-low–dose Lupron (ULDL) protocols can have comparable cycle...

    Zachary W. Walker, Andrea Lanes, ... Elizabeth S. Ginsburg in Journal of Assisted Reproduction and Genetics
    Article 16 June 2023
  7. Oocyte Quality and Blastocyst Formation Rate with Dual Stimulation in Patients Belonging to POSEIDON Groups 3 and 4: A Retrospective Comparative Study

    Aim

    To evaluate the oocyte retrieval rate and blastocyst formation rate with DuoStim protocol in patients belonging to POSEIDON groups 3 and 4.

    ...
    Article 21 October 2022
  8. Effects of letrozole co-treatment on outcomes of gonadotropin-releasing hormone antagonist cycles in POSEIDON groups 3 and 4 expected poor responders

    Purpose

    To evaluate the effects of adjuvant letrozole administration on outcomes of gonadotropin-releasing hormone (GnRH) antagonist cycles with...

    Alper Kahraman, Firat Tulek in Archives of Gynecology and Obstetrics
    Article 14 July 2022
  9. Significance of serum AMH and antral follicle count discrepancy for the prediction of ovarian stimulation response in Poseidon criteria patients

    Purpose

    To determine the risk of not being a poor responder in ovarian stimulation (OS) for in vitro fertilization (IVF) when ovarian reserve markers...

    Alyssa Hochberg, Michael H. Dahan, ... Sandro C. Esteves in Journal of Assisted Reproduction and Genetics
    Article 15 February 2024
  10. Human Menopausal Gonadotropin Commenced on Early Follicular Period Increases Live Birth Rates in POSEIDON Group 3 and 4 Poor Responders

    Human menopausal gonadotropin (hMG) has LH activity, and it may have beneficial effects in terms of oocyte quality and endometrial receptivity...

    Bülent Berker, Yavuz Emre Şükür, ... Ruşen Aytaç in Reproductive Sciences
    Article 24 August 2020
  11. Decreased GDF9 and BMP15 in follicle fluid and granulosa cells and outcomes of IVF-ET among young patients with low prognosis

    Purpose

    To analyze the level of growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) in follicle fluid (FF) and granulosa...

    Tian-hong Huang, Fu-rui Chen, ... Yan Gong in Journal of Assisted Reproduction and Genetics
    Article 23 January 2023
  12. Cumulative live birth rates for low-prognosis women over 5 years or 9 frozen-thawed embryo transfer cycles

    Background

    For heterogeneous populations of low-prognosis women, it remains unclear as to how long individuals should continue undergoing ART when...

    Di Chen, ** Kuang in BMC Pregnancy and Childbirth
    Article Open access 22 March 2022
  13. Presence of Endometrioma Does Not Impair Embryo Quality and Assisted Reproductive Technology (ART) Cycle Outcome in Diminished Ovarian Reserve (DOR) Patients

    This study aims to assess the impact of endometrioma on embryo quality and cycle outcome in patients who undergo assisted reproductive technology...

    Şeyma Osmanlıoğlu, Bülent Berker, ... Ruşen Aytaç in Reproductive Sciences
    Article 27 October 2022
  14. Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles

    Background

    Artificial oocyte activation (AOA) is used to improve fertilization rate following fertilization failure after intracytoplasmic sperm...

    Tzung-En Tsai, Pei-Hsuan Lin, ... Li-Te Lin in Journal of Ovarian Research
    Article Open access 09 September 2022
  15. Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon’s stratification: a retrospective multicenter cohort study

    Objective

    To investigate whether minimal ovarian stimulation (mOS) is as effective as conventional ovarian stimulation (cOS) for older women belonging...

    Mauro Cozzolino, Gustavo Nardini Cecchino, ... Nicolás Garrido in Journal of Assisted Reproduction and Genetics
    Article 13 April 2021
  16. The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study

    Background

    Vitrified M-II oocyte accumulation for later simultaneous insemination has been used for managing POR. Our study aimed to determine whether...

    Kuan-Sheng Lee, Ming-Huei Lin, ... Robert Kuo-Kuang Lee in Journal of Ovarian Research
    Article Open access 03 March 2023
  17. Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients

    Background

    Recent studies have consistently shown that AFC and serum AMH are good predictors of ovarian response and have shown strong correlations....

    Yaxin Guo, Huahua Jiang, ... Lei ** in Journal of Ovarian Research
    Article Open access 28 August 2021
  18. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis

    Context

    The effect of platelet-rich plasma (PRP) on ovarian reserve markers in poor ovarian response (POR) is challenging.

    Aim

    This systematic review...

    Mozhgan Vahabi Dastjerdi, Samaneh Sheibani, ... Rohollah Valizadeh in Archives of Gynecology and Obstetrics
    Article 08 April 2024
  19. Implication of Novel BMP15 and GDF9 Variants in Unexpected Poor Ovarian Response

    Unexpected poor ovarian response (UPOR) occurs when nine or fewer oocytes are retrieved from a young patient with normal ovarian reserve. Bone...

    Anahita Mehdizadeh, Mansoureh Soleimani, ... Zahra Zandieh in Reproductive Sciences
    Article 17 October 2023
  20. Transcriptomic profiling of human granulosa cells between women with advanced maternal age with different ovarian reserve

    Background

    Age-related diminished ovarian reserve (DOR) is not absolute. Some advanced maternal age (AMA) still have normal ovarian reserve (NOR) and...

    Zhi-cheng Jia, Yong-qian Li, ... Ying Guo in Journal of Assisted Reproduction and Genetics
    Article Open access 17 August 2023
Did you find what you were looking for? Share feedback.